Large Molecule Bioanalytical Testing Service Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global large molecule bioanalytical testing service market looks promising with opportunities in the oncology, infectious diseases, cardiology, and neurology therapeutic areas. The global large molecule bioanalytical testing service market is expected to grow with a CAGR of 8%-10% from 2020 to 2025. The major drivers for this market are increasing research and development expenditure in pharmaceutical and biopharmaceutical companies and rising share of large molecules in biopharmaceutical.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global large molecule bioanalytical testing service market report, please download the report brochure.
The study includes trends and forecast for the global large molecule bioanalytical testing service market by test type, type, phase, therapeutic area, end user, and region as follows:
By Test Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that anti drug antibody (ADA) will remain the largest segment over the forecast period due to increasing prevalence of chronic diseases as ADA assays support the development of large molecule drugs by detecting anti drug antibodies.
Within this market, small and medium enterprise will remain the largest segment by end user over the forecast period due to increasing investment in the biopharmaceutical industry to enhance productivity and efficiency which has driven the bio-manufacturers to increase their focus on outsourcing activities.
North America will remain the largest region over the forecast period due to presence of highly reliable, complex, and high-end pharmaceutical companies and rapid technological advancements in the region.
Features of the Global Large Molecule Bioanalytical Testing Service Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global large molecule bioanalytical testing service market by test type (ADME, PK, PD, bioavailability, bioequivalence, and other test), type (pharmacokinetics, ADA, and others), phase (preclinical, with antibody, without antibody, and clinical), therapeutic area (oncology, infectious diseases, cardiology, neurology, and others), end user (SMEs and large firms), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global large molecule bioanalytical testing service market?
Q.5 What are the business risks and threats to the global large molecule bioanalytical testing service market?
Q.6 What are the emerging trends in this large molecule bioanalytical testing service market and the reasons behind them?
Q.7 What are some changing demands of customers in this large molecule bioanalytical testing service market?
Q.8 What are the new developments in this large molecule bioanalytical testing service market? Which companies are leading these developments?
Q.9 Who are the major players in this large molecule bioanalytical testing service market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this large molecule bioanalytical testing service market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global large molecule bioanalytical testing service market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Test Type (ADME, PK, PD, Bioavailability, Bioequivalence, and Other Test), Type (Pharmacokinetics, ADA, and Others), Phase (Preclinical, With Antibody, Without Antibody, And Clinical), Therapeutic Area (Oncology, Infectious Diseases, Cardiology, Neurology, and Others), and End User (SMEs and Large Firms)
Regional Scope North America (USA, Mexico, and Canada), Europe (Norway, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global large molecule bioanalytical testing service market looks promising with opportunities in the oncology, infectious diseases, cardiology, and neurology therapeutic areas. The global large molecule bioanalytical testing service market is expected to grow with a CAGR of 8%-10% from 2020 to 2025. The major drivers for this market are increasing research and development expenditure in pharmaceutical and biopharmaceutical companies and rising share of large molecules in biopharmaceutical.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global large molecule bioanalytical testing service market report, please download the report brochure.
The study includes trends and forecast for the global large molecule bioanalytical testing service market by test type, type, phase, therapeutic area, end user, and region as follows:
By Test Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- ADME (Absorption, Distribution, Metabolism and Excretion)
- PK (Pyruvate Kinase)
- PD (Partial Discharge)
- Bioavailability
- Bioequivalence
- Other Test
- Pharmacokinetics
- Anti Drug Antibody (ADA)
- Others
- Preclinical
- With Antibody
- Without Antibody
- Clinical
- Oncology
- Infectious Diseases
- Cardiology
- Neurology
- Others
- Small and Mid Size Enterprise (SMEs)
- Large Firms
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that anti drug antibody (ADA) will remain the largest segment over the forecast period due to increasing prevalence of chronic diseases as ADA assays support the development of large molecule drugs by detecting anti drug antibodies.
Within this market, small and medium enterprise will remain the largest segment by end user over the forecast period due to increasing investment in the biopharmaceutical industry to enhance productivity and efficiency which has driven the bio-manufacturers to increase their focus on outsourcing activities.
North America will remain the largest region over the forecast period due to presence of highly reliable, complex, and high-end pharmaceutical companies and rapid technological advancements in the region.
Features of the Global Large Molecule Bioanalytical Testing Service Market
- Market Size Estimates: Global large molecule bioanalytical testing service market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global large molecule bioanalytical testing service market size by various segments, such as test type, type, phase, therapeutic area, and end user in terms of value.
- Regional Analysis: Global large molecule bioanalytical testing service market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different test type, type, phase, therapeutic area, end user, and region for the global large molecule bioanalytical testing service market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global large molecule bioanalytical testing service market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global large molecule bioanalytical testing service market by test type (ADME, PK, PD, bioavailability, bioequivalence, and other test), type (pharmacokinetics, ADA, and others), phase (preclinical, with antibody, without antibody, and clinical), therapeutic area (oncology, infectious diseases, cardiology, neurology, and others), end user (SMEs and large firms), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global large molecule bioanalytical testing service market?
Q.5 What are the business risks and threats to the global large molecule bioanalytical testing service market?
Q.6 What are the emerging trends in this large molecule bioanalytical testing service market and the reasons behind them?
Q.7 What are some changing demands of customers in this large molecule bioanalytical testing service market?
Q.8 What are the new developments in this large molecule bioanalytical testing service market? Which companies are leading these developments?
Q.9 Who are the major players in this large molecule bioanalytical testing service market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this large molecule bioanalytical testing service market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global large molecule bioanalytical testing service market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Test Type (ADME, PK, PD, Bioavailability, Bioequivalence, and Other Test), Type (Pharmacokinetics, ADA, and Others), Phase (Preclinical, With Antibody, Without Antibody, And Clinical), Therapeutic Area (Oncology, Infectious Diseases, Cardiology, Neurology, and Others), and End User (SMEs and Large Firms)
Regional Scope North America (USA, Mexico, and Canada), Europe (Norway, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Large Molecule Bioanalytical Testing Service Market Trends and Forecast
3.3: Global Large Molecule Bioanalytical Testing Service Market by Test Type
3.3.1: ADME (Absorption, Distribution, Metabolism and Excretion)
3.3.2: PK (Pyruvate Kinase)
3.3.3: PD (Partial Discharge)
3.3.4: Bioavailability
3.3.5: Bioequivalence
3.3.6: Other Test
3.4: Global Large Molecule Bioanalytical Testing Service Market by Type
3.4.1: Pharmacokinetics
3.4.2: Anti Drug Antibody (ADA)
3.4.3: Others
3.5: Global Large Molecule Bioanalytical Testing Service Market by Phase
3.5.1: Preclinical
3.5.2: With Antibody
3.5.3: Without Antibody
3.5.4: Clinical
3.6: Global Large Molecule Bioanalytical Testing Service Market by Therapeutic Area
3.6.1: Oncology
3.6.2: Infectious Diseases
3.6.3: Cardiology
3.6.4: Neurology
3.6.5: Others
3.7: Global Large Molecule Bioanalytical Testing Service Market by End User
3.7.1: Small and Mid Size Enterprise (SMEs)
3.7.2: Large Firms
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Large Molecule Bioanalytical Testing Service Market by Region
4.2: North American Large Molecule Bioanalytical Testing Service Market
4.2.1: Market by Test Type: ADME (Absorption, Distribution, Metabolism and Excretion), PK (Pyruvate Kinase), PD (Partial Discharge), Bioavailability, Bioequivalence, and Other Test
4.2.2: Market by Type: Pharmacokinetics, Anti Drug Antibody (ADA), and Others
4.2.3: Market by Phase: Preclinical,With Antibody, Without Antibody (ELISA Based Assay), and Clinical
4.2.4: Market by Therapeutic Area: Oncology, Infectious Diseases, Cardiology, Neurology, and Others
4.2.5: Market by End User: Small and Mid Size Enterprise (SMEs) and Large Firms
4.2.6: The United States Large Molecule Bioanalytical Testing Service Market
4.2.7:The Canadian Large Molecule Bioanalytical Testing Service Market
4.2.8: The Mexican Large Molecule Bioanalytical Testing Service Market
4.3: European Large Molecule Bioanalytical Testing Service Market
4.3.1: Market by Test Type: ADME (Absorption, Distribution, Metabolism and Excretion), PK (Pyruvate Kinase), PD (Partial Discharge), Bioavailability, Bioequivalence, and Other Test
4.3.2: Market by Type: Pharmacokinetics, Anti Drug Antibody (ADA), and Others
4.3.3: Market by Phase: Preclinical,With Antibody, Without Antibody (ELISA Based Assay), and Clinical
4.3.4: Market by Therapeutic Area: Oncology, Infectious Diseases, Cardiology, Neurology, and Others
4.3.5: Market by End User: Small and Mid Size Enterprise (SMEs) and Large Firms
4.3.6: The Large Molecule Bioanalytical Testing Service Market of United Kingdom
4.3.7: The German Large Molecule Bioanalytical Testing Service Market
4.3.8: The French Large Molecule Bioanalytical Testing Service Market
4.4: APAC Large Molecule Bioanalytical Testing Service Market
4.4.1: Market by Test Type: ADME (Absorption, Distribution, Metabolism and Excretion), PK (Pyruvate Kinase), PD (Partial Discharge), Bioavailability, Bioequivalence, and Other Test
4.4.2: Market by Type: Pharmacokinetics, Anti Drug Antibody (ADA), and Others
4.4.3: Market by Phase: Preclinical,With Antibody, Without Antibody (ELISA Based Assay), and Clinical
4.4.4: Market by Therapeutic Area: Oncology, Infectious Diseases, Cardiology, Neurology, and Others
4.4.5: Market by End User: Small and Mid Size Enterprise (SMEs) and Large Firms
4.4.6: The Chinese Large Molecule Bioanalytical Testing Service Market
4.4.7: The Indian Large Molecule Bioanalytical Testing Service Market
4.4.8: The Japanese Large Molecule Bioanalytical Testing Service Market
4.5: ROW Large Molecule Bioanalytical Testing Service Market
4.5.1: Market by Test Type: ADME (Absorption, Distribution, Metabolism and Excretion), PK (Pyruvate Kinase), PD (Partial Discharge), Bioavailability, Bioequivalence, and Other Test
4.5.2:Market by Type: Pharmacokinetics, Anti Drug Antibody (ADA), and Others
4.5.3: Market by Phase: Preclinical,With Antibody, Without Antibody (ELISA Based Assay), and Clinical
4.5.4: Market by Therapeutic Area: Oncology, Infectious Diseases, Cardiology, Neurology, and Others
4.5.5: Market by End User: Small and Mid Size Enterprise (SMEs) and Large Firms
4.5.6: Brazilian Large Molecule Bioanalytical Testing Service Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Test Type
7.1.2: Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Type
7.1.3: Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Phase
7.1.4: Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Therapeutic Area
7.1.5: Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by End User
7.1.6: Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Region
7.2: Emerging Trends in the Global Large Molecule Bioanalytical Testing Service Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Large Molecule Bioanalytical Testing Service Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Large Molecule Bioanalytical Testing Service Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Covance, Inc.
8.2: IQVIA
8.3: Syneos Health
8.4: SGS SA
8.5: Toxikon
8.6: Intertek Group plc
8.7: Pace Analytical Services LLC
8.8: Charles River LaboratoryInternational
8.9: ICON Plc
8.10: PPD, Inc.
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Large Molecule Bioanalytical Testing Service Market Trends and Forecast
3.3: Global Large Molecule Bioanalytical Testing Service Market by Test Type
3.3.1: ADME (Absorption, Distribution, Metabolism and Excretion)
3.3.2: PK (Pyruvate Kinase)
3.3.3: PD (Partial Discharge)
3.3.4: Bioavailability
3.3.5: Bioequivalence
3.3.6: Other Test
3.4: Global Large Molecule Bioanalytical Testing Service Market by Type
3.4.1: Pharmacokinetics
3.4.2: Anti Drug Antibody (ADA)
3.4.3: Others
3.5: Global Large Molecule Bioanalytical Testing Service Market by Phase
3.5.1: Preclinical
3.5.2: With Antibody
3.5.3: Without Antibody
3.5.4: Clinical
3.6: Global Large Molecule Bioanalytical Testing Service Market by Therapeutic Area
3.6.1: Oncology
3.6.2: Infectious Diseases
3.6.3: Cardiology
3.6.4: Neurology
3.6.5: Others
3.7: Global Large Molecule Bioanalytical Testing Service Market by End User
3.7.1: Small and Mid Size Enterprise (SMEs)
3.7.2: Large Firms
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Large Molecule Bioanalytical Testing Service Market by Region
4.2: North American Large Molecule Bioanalytical Testing Service Market
4.2.1: Market by Test Type: ADME (Absorption, Distribution, Metabolism and Excretion), PK (Pyruvate Kinase), PD (Partial Discharge), Bioavailability, Bioequivalence, and Other Test
4.2.2: Market by Type: Pharmacokinetics, Anti Drug Antibody (ADA), and Others
4.2.3: Market by Phase: Preclinical,With Antibody, Without Antibody (ELISA Based Assay), and Clinical
4.2.4: Market by Therapeutic Area: Oncology, Infectious Diseases, Cardiology, Neurology, and Others
4.2.5: Market by End User: Small and Mid Size Enterprise (SMEs) and Large Firms
4.2.6: The United States Large Molecule Bioanalytical Testing Service Market
4.2.7:The Canadian Large Molecule Bioanalytical Testing Service Market
4.2.8: The Mexican Large Molecule Bioanalytical Testing Service Market
4.3: European Large Molecule Bioanalytical Testing Service Market
4.3.1: Market by Test Type: ADME (Absorption, Distribution, Metabolism and Excretion), PK (Pyruvate Kinase), PD (Partial Discharge), Bioavailability, Bioequivalence, and Other Test
4.3.2: Market by Type: Pharmacokinetics, Anti Drug Antibody (ADA), and Others
4.3.3: Market by Phase: Preclinical,With Antibody, Without Antibody (ELISA Based Assay), and Clinical
4.3.4: Market by Therapeutic Area: Oncology, Infectious Diseases, Cardiology, Neurology, and Others
4.3.5: Market by End User: Small and Mid Size Enterprise (SMEs) and Large Firms
4.3.6: The Large Molecule Bioanalytical Testing Service Market of United Kingdom
4.3.7: The German Large Molecule Bioanalytical Testing Service Market
4.3.8: The French Large Molecule Bioanalytical Testing Service Market
4.4: APAC Large Molecule Bioanalytical Testing Service Market
4.4.1: Market by Test Type: ADME (Absorption, Distribution, Metabolism and Excretion), PK (Pyruvate Kinase), PD (Partial Discharge), Bioavailability, Bioequivalence, and Other Test
4.4.2: Market by Type: Pharmacokinetics, Anti Drug Antibody (ADA), and Others
4.4.3: Market by Phase: Preclinical,With Antibody, Without Antibody (ELISA Based Assay), and Clinical
4.4.4: Market by Therapeutic Area: Oncology, Infectious Diseases, Cardiology, Neurology, and Others
4.4.5: Market by End User: Small and Mid Size Enterprise (SMEs) and Large Firms
4.4.6: The Chinese Large Molecule Bioanalytical Testing Service Market
4.4.7: The Indian Large Molecule Bioanalytical Testing Service Market
4.4.8: The Japanese Large Molecule Bioanalytical Testing Service Market
4.5: ROW Large Molecule Bioanalytical Testing Service Market
4.5.1: Market by Test Type: ADME (Absorption, Distribution, Metabolism and Excretion), PK (Pyruvate Kinase), PD (Partial Discharge), Bioavailability, Bioequivalence, and Other Test
4.5.2:Market by Type: Pharmacokinetics, Anti Drug Antibody (ADA), and Others
4.5.3: Market by Phase: Preclinical,With Antibody, Without Antibody (ELISA Based Assay), and Clinical
4.5.4: Market by Therapeutic Area: Oncology, Infectious Diseases, Cardiology, Neurology, and Others
4.5.5: Market by End User: Small and Mid Size Enterprise (SMEs) and Large Firms
4.5.6: Brazilian Large Molecule Bioanalytical Testing Service Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Test Type
7.1.2: Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Type
7.1.3: Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Phase
7.1.4: Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Therapeutic Area
7.1.5: Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by End User
7.1.6: Growth Opportunities for the Global Large Molecule Bioanalytical Testing Service Market by Region
7.2: Emerging Trends in the Global Large Molecule Bioanalytical Testing Service Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Large Molecule Bioanalytical Testing Service Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Large Molecule Bioanalytical Testing Service Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Covance, Inc.
8.2: IQVIA
8.3: Syneos Health
8.4: SGS SA
8.5: Toxikon
8.6: Intertek Group plc
8.7: Pace Analytical Services LLC
8.8: Charles River LaboratoryInternational
8.9: ICON Plc
8.10: PPD, Inc.
